FDA plans ultra-fast review of three psychedelic drugs following Trump directive
Summary
The Food and Drug Administration said Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, inclu...
Description
The Food and Drug Administration said Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, inclu...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source